ADMA suit shakes risk mood as Polymarket still prices 80% odds of zero 2026 cuts

By Blockchain News | Created at 2026-06-22 20:14:30 | Updated at 2026-06-24 04:41:11 1 day ago

ADMA Biologics Securities Lawsuit Triggers Risk-Off Mood as Polymarket “0 Fed Cuts in 2026” Slips to 80.25%

A federal securities lawsuit targeting ADMA Biologics has put fresh focus on allegations of inflated revenue reporting, a risk-off backdrop that has coincided with a small dip in Polymarket pricing for "How many Fed rate cuts in 2026?". On Polymarket, the leading outcome remains "0 (0 bps)" at 80.25%, down from 82.1%.

Key Takeaways

Polymarket prices a 80.25% chance that the Federal Reserve makes 0 rate cuts (0 bps) in 2026.
The contract ticked lower after news of a federal securities lawsuit alleging revenue inflation and related-party disclosure issues at ADMA Biologics.
The market resolves on 2026-12-31, with the latest "0 cuts" odds down 1.85 percentage points to 80.25%.

ADMA Biologics is facing a federal securities lawsuit that alleges the company inflated revenues for its flagship product through channel stuffing and failed to disclose a distribution relationship tied to an entity allegedly controlled by a senior executive. The complaint was filed in the U.S. District Court for the District of New Jersey and claims ADMA and certain senior executives made materially false and misleading statements about revenue growth, internal controls, and related-party transactions. The allegations followed a short-seller report published on March 24, 2026. ADMA shares fell about 16.6% on March 24, another 15% on March 25, and a further 13.9% on March 26, ending at $8.29 versus roughly $13.59 before the report. Separately, an analyst at Raymond James resumed coverage on June 10, 2026 with an Outperform rating and a $21 price target, describing ADMA as a profitable, high-growth company with U.S.-based manufacturing and sales.

Polymarket Data: $37.38M Volume and a Steep Odds Curve—0 Cuts at 80.25% vs 1 Cut at 13.5% and 2 Cuts at 2.45%

Polymarket shows $37.38 million in volume on the ladder market "How many Fed rate cuts in 2026?" with the "0 (0 bps)" rung still dominant at 80.25% Yes versus 19.75% No. The curve drops sharply after that: "1 (25 bps)" sits at 13.5% Yes / 86.5% No, while "2 (50 bps)" is priced at 2.45% Yes / 97.55% No. Longer-tail outcomes are priced as remote, with "3 (75 bps)" at 0.85% Yes / 99.15% No and "4 (100 bps)" at 0.45% Yes / 99.55% No, indicating traders are heavily concentrated in the no-cuts base case rather than distributing exposure across multiple cut counts.

Traders will be watching whether pricing continues to cluster around the "0 (0 bps)" rung or migrates toward the "1 (25 bps)" and "2 (50 bps)" rungs as the 2026-12-31 resolution date approaches.

Beyond Fed Rate Cuts: Other High-Volume Macro and Geopolitical Contracts Polymarket Traders Are Watching

Beyond the 2026 easing debate, Polymarket flow is also clustering around nearer-term policy and corporate catalysts. In “Fed Decision in July?”, traders give 74.5% odds to “No change” on $15.64 million in volume, while “Largest IPO by market cap in 2026?” continues to lean heavily toward “SpaceX” at 85.5% on $2.80 million, underscoring how macro pricing and headline-driven deal speculation are coexisting on the same tape.

Odds Trend

WindowChange (pp)

24h	+2.2
7d	+2.2

By the Numbers

Platform: Polymarket
Market: How many Fed rate cuts in 2026?
Contract type: Price strike ladder: each rung has separate Yes/No; Yes means the spot price is above that USD strike at settlement.
Resolution window: Dec 31, 2026 (UTC)
Status: Active (open for trading)
Volume: ~$37,379,010

Top strike rungs

StrikeYesNo